MASTORINO, L.; SILIQUINI, N.; AVALLONE, G.; ORTONCELLI, M.; QUAGLINO, P.; DAPAVO, P.; RIBERO, S. Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis. Dermatology Reports, [S. l.], v. 14, n. 3, 2022. DOI: 10.4081/dr.2022.9282. Disponível em: https://www.pagepress.org/journals/dr/article/view/9282. Acesso em: 22 nov. 2024.